Goldwind Science & Technology (02208) reported net profit attributable to shareholders of approximately RMB 2.875 billion for the first three quarters, up 11.25% year on year.
Goldwind Science & Technology (02208) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB 52.023 billion, up 8.05% year on year; net profit attributable to shareholders of the listed company of approximately RMB 2.875 billion, up 11.25% year on year; and basic earnings per share of RMB 0.6594.
Goldwind Science & Technology (02208) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB 52.023 billion, up 8.05% year on year; net profit attributable to shareholders of the listed company of approximately RMB 2.875 billion, up 11.25% year on year; and basic earnings per share of RMB 0.6594.
As of September 30, 2026, the company's total external order backlog was 39,877.57MW, comprising: 4,112.35MW for units below 6MW, 27,604.52MW for units of 6MW (inclusive) to 10MW, and 8,160.70MW for units of 10MW and above; the company's external winning bids with unsigned contracts totaled 15,227.35MW, including 753.00MW for units below 6MW, 9,063.35MW for units of 6MW (inclusive) to 10MW, and 5,411.00MW for units of 10MW and above; the company's total external orders in hand amounted to 55,104.92MW, of which overseas orders were 11,046.37MW; in addition, the company had internal orders of 1,865.30MW. The company's total orders in hand amounted to 56,970.22MW, up 8.60% year on year.
Related Articles

ANTON OILFIELD (03337): Adoption of Employee Compensation Share Purchase Support Plan

MOBVISTA (01860) repurchased 479,000 shares on October 23 for HK$4.7178 million.

HAOHAI BIOTEC (06826) reported a net profit attributable to shareholders of approximately RMB 163 million for the first three quarters, a year-on-year decrease of 46.53%.
ANTON OILFIELD (03337): Adoption of Employee Compensation Share Purchase Support Plan

MOBVISTA (01860) repurchased 479,000 shares on October 23 for HK$4.7178 million.

HAOHAI BIOTEC (06826) reported a net profit attributable to shareholders of approximately RMB 163 million for the first three quarters, a year-on-year decrease of 46.53%.






